Zimmermann Michael B, Hess Sonja Y, Adou Pierre, Toresanni Toni, Wegmüller Rita, Hurrell Richard F
Human Nutrition Laboratory, Institute of Food Science and Nutrition, Swiss Federal Institute of Technology, Zürich, Switzerland.
Am J Clin Nutr. 2003 Mar;77(3):663-7. doi: 10.1093/ajcn/77.3.663.
The long-term goal of salt iodization is elimination of iodine deficiency and reduction of the goiter rate to < 5% in school-aged children. Normalization of the goiter rate probably indicates disappearance of iodine deficiency disorders as a public health problem. However, thyroid size may not return to normal for months or years after correction of iodine deficiency.
We described the time course and pattern of changes in thyroid size and goiter rate in response to the introduction of iodized salt in an area of severe endemic goiter.
In a 5-y prospective study, we measured thyroid size by ultrasonography and urinary iodine and thyroid hormone concentrations in schoolchildren 6 mo before the introduction of iodized salt and annually for 4 y thereafter.
Four years after the introduction of iodized salt and normalization of the median urinary iodine concentration, mean thyroid size had decreased 56% (P < 0.0001). However, 29% of the children remained goitrous, with a significant age shift in the distribution of goiter. At baseline, the goiter rate was significantly higher in younger (age: 5-9 y) than in older (age: 10-14 y) children (P < 0.0001). At 2, 3, and 4 y after salt iodization, the goiter rate was significantly higher in the older than in the younger children (at 4 y: 52% compared with 19%), and the difference increased with time (P < 0.0001).
The goiter rate in school-aged children may remain sharply elevated for up to 4 y after successful introduction of iodized salt, primarily because of persistent goiter in older children.
食盐加碘的长期目标是消除碘缺乏,并将学龄儿童的甲状腺肿发生率降低至<5%。甲状腺肿发生率恢复正常可能表明碘缺乏症作为一个公共卫生问题已消失。然而,在碘缺乏得到纠正后的数月或数年里,甲状腺大小可能不会恢复正常。
我们描述了在一个严重地方性甲状腺肿地区引入碘盐后,甲状腺大小和甲状腺肿发生率随时间的变化过程和模式。
在一项为期5年的前瞻性研究中,我们在引入碘盐前6个月通过超声测量学龄儿童的甲状腺大小,并检测其尿碘和甲状腺激素浓度,此后每年检测一次,持续4年。
引入碘盐且尿碘中位数浓度恢复正常4年后,平均甲状腺大小减小了56%(P<0.0001)。然而,29%的儿童仍患有甲状腺肿,甲状腺肿的分布存在明显的年龄差异。基线时,年龄较小(5-9岁)儿童的甲状腺肿发生率显著高于年龄较大(10-14岁)儿童(P<0.0001)。在碘盐引入后的第2、3和4年,年龄较大儿童的甲状腺肿发生率显著高于年龄较小儿童(第4年:52%对19%),且这种差异随时间增加(P<0.0001)。
成功引入碘盐后,学龄儿童的甲状腺肿发生率可能在长达4年内仍急剧升高,主要原因是年龄较大儿童的甲状腺肿持续存在。